TNGX logo

Tango Therapeutics, Inc. (TNGX) Operating Profit

Annual Operating Profit:

-$145.59M-$31.42M(-27.52%)
December 31, 2024

Summary

  • As of today, TNGX annual operating income is -$145.59 million, with the most recent change of -$31.42 million (-27.52%) on December 31, 2024.
  • During the last 3 years, TNGX annual operating profit has fallen by -$87.41 million (-150.21%).
  • TNGX annual operating profit is now -178.92% below its all-time high of -$52.20 million, reached on December 31, 2020.

Performance

TNGX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNGXincome statement metrics

Quarterly Operating Profit:

-$40.97M+$1.56M(+3.68%)
June 30, 2025

Summary

  • As of today, TNGX quarterly operating income is -$40.97 million, with the most recent change of +$1.56 million (+3.68%) on June 30, 2025.
  • Over the past year, TNGX quarterly operating profit has dropped by -$11.41 million (-38.63%).
  • TNGX quarterly operating profit is now -8193300.00% below its all-time high of -$500.00, reached on June 30, 2020.

Performance

TNGX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNGXincome statement metrics

TTM Operating Profit:

-$157.28M-$11.41M(-7.83%)
June 30, 2025

Summary

  • As of today, TNGX TTM operating income is -$157.28 million, with the most recent change of -$11.41 million (-7.83%) on June 30, 2025.
  • Over the past year, TNGX TTM operating profit has dropped by -$24.84 million (-18.75%).
  • TNGX TTM operating profit is now -31456900.00% below its all-time high of -$500.00, reached on June 30, 2020.

Performance

TNGX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNGXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

TNGX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-27.5%-38.6%-18.8%
3Y3 Years-150.2%-62.5%-70.7%
5Y5 Years-178.9%-10000.0%-487.8%

TNGX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-150.2%at low-76.2%+3.7%-53.5%at low
5Y5-Year-178.9%at low-799.2%+3.7%-487.8%at low
All-TimeAll-Time-178.9%at low>-9999.0%+3.7%>-9999.0%at low

TNGX Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$40.97M(+3.7%)
-$157.28M(-7.8%)
Mar 2025
-
-$42.53M(-4.0%)
-$145.87M(-0.2%)
Dec 2024
-$145.59M(-27.5%)
-$40.91M(-24.4%)
-$145.59M(-4.2%)
Sep 2024
-
-$32.88M(-11.3%)
-$139.70M(-5.5%)
Jun 2024
-
-$29.55M(+30.1%)
-$132.45M(-5.0%)
Mar 2024
-
-$42.26M(-20.7%)
-$126.14M(-10.5%)
Dec 2023
-$114.17M(-2.8%)
-$35.01M(-36.6%)
-$114.17M(-4.1%)
Sep 2023
-
-$25.63M(-10.2%)
-$109.73M(+3.8%)
Jun 2023
-
-$23.25M(+23.2%)
-$114.02M(+1.7%)
Mar 2023
-
-$30.29M(+0.9%)
-$115.98M(-4.4%)
DateAnnualQuarterlyTTM
Dec 2022
-$111.07M(-90.9%)
-$30.57M(-2.2%)
-$111.07M(-8.4%)
Sep 2022
-
-$29.92M(-18.7%)
-$102.49M(-11.2%)
Jun 2022
-
-$25.20M(+0.7%)
-$92.13M(-28.9%)
Mar 2022
-
-$25.38M(-15.4%)
-$71.49M(-22.9%)
Dec 2021
-$58.19M(-11.5%)
-$21.98M(-12.3%)
-$58.19M(-28.9%)
Sep 2021
-
-$19.57M(-329.5%)
-$45.14M(+13.7%)
Jun 2021
-
-$4.56M(+62.3%)
-$52.33M(-9.5%)
Mar 2021
-
-$12.08M(-35.2%)
-$47.78M(-33.8%)
Dec 2020
-$52.20M
-$8.94M(+66.6%)
-$35.69M(-33.4%)
Sep 2020
-
-$26.76M(>-9900.0%)
-$26.76M(>-9900.0%)
Jun 2020
-
-$500.00
-$500.00

FAQ

  • What is Tango Therapeutics, Inc. annual operating income?
  • What is the all-time high annual operating profit for Tango Therapeutics, Inc.?
  • What is Tango Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Tango Therapeutics, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Tango Therapeutics, Inc.?
  • What is Tango Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Tango Therapeutics, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Tango Therapeutics, Inc.?
  • What is Tango Therapeutics, Inc. TTM operating profit year-on-year change?

What is Tango Therapeutics, Inc. annual operating income?

The current annual operating profit of TNGX is -$145.59M

What is the all-time high annual operating profit for Tango Therapeutics, Inc.?

Tango Therapeutics, Inc. all-time high annual operating income is -$52.20M

What is Tango Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, TNGX annual operating income has changed by -$31.42M (-27.52%)

What is Tango Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of TNGX is -$40.97M

What is the all-time high quarterly operating profit for Tango Therapeutics, Inc.?

Tango Therapeutics, Inc. all-time high quarterly operating income is -$500.00

What is Tango Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, TNGX quarterly operating income has changed by -$11.41M (-38.63%)

What is Tango Therapeutics, Inc. TTM operating income?

The current TTM operating profit of TNGX is -$157.28M

What is the all-time high TTM operating profit for Tango Therapeutics, Inc.?

Tango Therapeutics, Inc. all-time high TTM operating income is -$500.00

What is Tango Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, TNGX TTM operating income has changed by -$24.84M (-18.75%)
On this page